Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Eickhoff

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Neurology|August 18, 1977
Serological response of multiple sclerosis patients and controls to 6/94-parainfluenza virusJ Wikström, D W Meyer, K Eickhoff, et al.
Journal of Diabetes and Its Complications|April 29, 2020
Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trialMie K Eickhoff, Flemming J Olsen, Marie Frimodt-Møller, et al.
Frontiers in Pharmacology|May 16, 2022
Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator ReceptorViktor Rotbain Curovic, Morten B Houlind, Tine W Hansen, et al.
Immunobiology|March 22, 2024
Effect of dapagliflozin on collectins and complement activation in plasma from patients with type 2 diabetes and albuminuria: Data from the DapKid cohortMia Jensen, Mie K Eickhoff, Frederik Persson, et al.
Acta Diabetologica|August 15, 2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patientsViktor Rotbain Curovic, Tine W Hansen, Mie K Eickhoff, et al.
Kidney International Reports|February 12, 2024
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney DiseaseTarunveer S Ahluwalia, Teemu K E Rönkkö, Mie K Eickhoff, et al.
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Journal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neurology|August 18, 1977
Serological response of multiple sclerosis patients and controls to 6/94-parainfluenza virusJ Wikström, D W Meyer, K Eickhoff, et al.
Journal of Diabetes and Its Complications|April 29, 2020
Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trialMie K Eickhoff, Flemming J Olsen, Marie Frimodt-Møller, et al.
Frontiers in Pharmacology|May 16, 2022
Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator ReceptorViktor Rotbain Curovic, Morten B Houlind, Tine W Hansen, et al.
Immunobiology|March 22, 2024
Effect of dapagliflozin on collectins and complement activation in plasma from patients with type 2 diabetes and albuminuria: Data from the DapKid cohortMia Jensen, Mie K Eickhoff, Frederik Persson, et al.
Acta Diabetologica|August 15, 2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patientsViktor Rotbain Curovic, Tine W Hansen, Mie K Eickhoff, et al.
Kidney International Reports|February 12, 2024
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney DiseaseTarunveer S Ahluwalia, Teemu K E Rönkkö, Mie K Eickhoff, et al.
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Journal of Clinical Medicine|June 5, 2019
Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System InhibitorsMie K Eickhoff, Claire C J Dekkers, Bart J Kramers, et al.
Pageof 3